Sign in
Taking people in United StatesNo phase

Collecting Samples and Data From People With Allergic Diseases Over Time

Studies blood, tissue and health data from people with allergy and sinus conditions.

Key facts

Who runs it
National Institute of Allergy and Infectious Diseases (NIAID)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Status
Recruiting
People taking part
10,000 people, planned
Started
28 Jan 2025
Expected to end
1 Nov 2045
Type of study
Observational, 3 groups
Record updated
15 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 3 to 100 years with allergic, atopic, respiratory or nose and sinus diseases, or a history of an immediate allergic reaction. Data, blood, fluid and tissue samples are collected.

Age
3 to 100 years
Sex
All sexes
Disease stage
Suspected or confirmed allergic, atopic, respiratory or nose/sinus disorder, or a suspected or confirmed immune dysregulatory disorder, or a history of an immediate hypersensitivity reaction to airborne allergens, food, insect stings or medicines

Main reasons for not taking part

  • Any condition the investigator feels rules out taking part
  • Pregnant people cannot have extra skin biopsies, extra nasal polyp biopsies or skin prick tests
  • Children under 18 years cannot have extra skin biopsies, nasal polyp biopsies or endoscopic biopsies
  • Uncontrolled asthma or a history of bad reaction to sedation or anesthesia (endoscopic biopsy only)
  • Blood thinners that cannot be stopped (nasal polyp and endoscopic biopsies)

The registry criteria, word for word

Show all 11 criteriaShow less

Who cannot take part

  • Any condition(s) or diagnosis, physical and/or psychological, that the investigator feels precludes the patient from participation in the study
  • Endoscopic Biopsy; Uncontrolled asthma or Grade 3 or higher by the American Society of Anesthesiologist's Physical Status Classification System (https://www.asahq.org/standards-and-practice-parameters/statement-on-asaphysical-status-classification-system); History of adverse reaction to conscious sedation or general anesthesia required for endoscopy; Hemoglobin < 11 g/dL; Platelet count < 100,000 microL; Pregnant or breastfeeding; Severe hypoxemia due to chronic pulmonary disease; Recent abdominal surgery; Anticoagulant therapy that cannot be interrupted; Younger than 18 years of age; Participants will be selected in an equitable manner from the available pool of potentially eligible individuals, without regard to factors such as sex, gender, race, ethnicity, sexual orientation, or socioeconomic status
  • For additional skin biopsies only:; Individuals who have a history of keloid formation; Children (<18 years old); Participants who are pregnant
  • For additional nasal-sinus polyp biopsies only:; Individuals on blood thinners unless they have already been stopped for the procedure; Children (<18 years old); Participants who are pregnant
  • An individual who meets any of the following criteria will be excluded from participation in this
  • study:
  • For skin prick testing; Participants who are pregnant

Other criteria

  • INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:; 1)Aged 3 to 100 years; 2a) Suspected or confirmed allergic, atopic, respiratory, or nasal/sinus disorder or have suspected or confirmed history of an immune dysregulatory disorder, OR; 2b) Have a clinical history of an immediate hypersensitivity reaction to aeroallergens, food, insect stings, or medications
  • Able to provide informed consent
  • Have or are willing to obtain a non-NIH primary physician who will manage all health conditions and be responsive for emergency medical treatment, if required
  • Willing to allow storage of blood, skin swabs, nasal fluid/brushings, bodily fluids, and other clinically appropriate tissue specimens or data generated during participation for future use in medical research

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 100 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: NIH Clinical Center Office of Patient Recruitment (OPR)Taking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

Allergic or sinus diseases can affect the skin, sinuses, airways, and other parts of the body. Examples include pollen and environmental allergies, food allergies, asthma, and eczema. To learn more about how to prevent and treat these diseases, researchers need to study data, blood, fluid, and tissue samples from people affected by them.

Objective:

To collect data, blood, fluid, and tissue samples from people with allergic or sinus diseases.

Eligibility:

People aged 3 to 100 years with allergic or sinus diseases.

Design:

Participants will have at least one clinic visit, and most participants will have a baseline visit, annual visit, and an end of study visit. The duration of the study is 1 to 3 years. During the first clinic visit, the following procedures will be done to collect data, blood, fluid, and tissue samples:

* Blood will be collected. * Cells and fluid may be collected from the inside of the nose using a long swab, and a small piece of skin may be scraped from inside the nose. * Skin cells will be collected by rubbing with a cotton swab. * A urine sample will be collected. * Allergy skin prick tests. Allergy-causing substances will be placed on the back or arm and the skin underneath gently scratched. If the participant is allergic to the substance, the skin may become red, itchy, and swollen locally ( at the site of the test). * Lung function test. Participants will breathe into a machine that measures the air moving in and out of their lungs. * If, as part of their routine care, participants are undergoing procedures such as having nasal polyps removed, skin tissue samples taken, or gastrointestinal biopsies, additional tissues may be collected for this study. * Participants will complete online questionnaires regarding their symptoms, health, and life.

Participants may return for more visits for up to 3 years.

The 3 groups in the trial

  • Conditions that may be initially evaluated or managed by A&amp;I but not categorized in 1 or 2 above

    Conditions that may be initially evaluated or managed by an allergist-immunologist or rhinologist but not categorized in (1) or (2) above (eg, hypereosinophilia, mast cell disorders, pruritus, chronic cough, smell disorders)

  • Individuals with a suspected allergic or atopic disease

    Individuals with a suspected allergic or atopic disease, but without demonstrated allergen sensitization (eg, contact hypersensitivity, chronic spontaneous urticaria, drug allergy)

  • Individuals with an allergic, atopic, or sinus disease

    Individuals with an allergic, atopic, or sinus disease (eg, atopic dermatitis, eosinophilic esophagitis (EoE), asthma, chronic rhinosinusitis with polyposis) with documented allergen sensitization in the skin or blood

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-up
Plain-language title
Collecting Samples and Data From People With Allergic Diseases Over TimeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06732414, who can take part
Record updated
15 October 2026